U.S. Metals and Mining Stock News

Pharvaris (NasdaqGS:PHVS) recently released real world data on hereditary angioedema attacks, focusing on how patients report symptoms and improvement. This provides investors with fresh context for its oral deucrictibant program. See our latest analysis for Pharvaris. Following this clinical progress, Pharvaris shares trade at US$26.38, with a 90 day share price return of 9.19% and a 1 year total shareholder return of 56%. This suggests momentum has been building over the longer term despite...

Oklo Inc. and Centrus Energy (LEU) are exploring a joint venture for high assay low enriched uranium deconversion at Centrus’ Piketon, Ohio site, connecting enrichment, advanced fuel services, and U.S. nuclear supply security. See our latest analysis for Centrus Energy. The joint venture talks with Oklo and Centrus Energy’s recent AI partnership with Palantir come against a backdrop of sharp share price swings, with a 7.24% 1 day share price return and 10.59% 7 day share price return...

Peloton Interactive (PTON) is back in focus after a mixed set of financial updates, an increase in profit guidance for fiscal 2026, and the upcoming handover of CFO responsibilities to interim finance chief Saqib Baig. See our latest analysis for Peloton Interactive. Despite the uplift in Adjusted EBITDA guidance and new product launches such as Peloton IQ, the share price has been weak, with a 30 day share price return of 13.33% decline and a 1 year total shareholder return of 37.89%...

Recently, National Health Investors reported fourth-quarter 2025 results that exceeded analyst expectations, with revenue coming in well ahead of prior forecasts. Analyst commentary has highlighted that the company’s solid financial position may support future acquisition activity without placing undue pressure on its balance sheet. We’ll now examine how National Health Investors’ stronger-than-expected earnings and acquisition capacity may influence its existing investment narrative. AI is...

Q4 and full year results in focus Weis Markets (WMK) has drawn investor attention after reporting fourth quarter and full year 2025 results, with higher sales, softer net income and continued investment in pricing, stores, technology and e-commerce capabilities. See our latest analysis for Weis Markets. Weis Markets’ latest results come after a softer patch in the share price, with a 30 day share price return of 12% decline and a 1 year total shareholder return of 17.3% decline. This suggests...

Steven Madden (SHOO) has been in focus after sharp price swings tied to geopolitical tensions with Iran, a strong fourth quarter earnings beat, and fresh insider selling that sharpened investor attention on the stock. See our latest analysis for Steven Madden. Those sharp swings over the past few days sit on top of a weaker recent trend, with a 30 day share price return of 11.69% decline and a 90 day share price return of 25.22% decline, even though the 1 year total shareholder return of...

Recent performance snapshot GRAIL (GRAL) has drawn attention after a recent slide in its share price, with the stock down about 5% over the past day and posting steeper declines over the past month. See our latest analysis for GRAIL. At a share price of $44.34, GRAIL’s recent 30 day share price return of 57.23% and year to date share price return of 50.11% contrast sharply with a 1 year total shareholder return of 64.71%. This suggests momentum has faded as investors reassess growth prospects...

Western Digital (WDC) is back on many watchlists after a strong past 3 months, with the stock showing a 48.1% total return, while recent daily and monthly moves have been more mixed. See our latest analysis for Western Digital. At a share price of $261.18, Western Digital’s 48.1% 3 month share price return sits alongside a very large 1 year total shareholder return. This suggests recent momentum has been strong even with a softer 1 day move. If Western Digital’s surge has caught your eye, it...

With no single headline event driving Stellar Bancorp (STEL) today, the stock’s recent performance and fundamentals, including US$413.252m in revenue and US$102.872m in net income, provide a concise snapshot of its current profile. See our latest analysis for Stellar Bancorp. Stellar Bancorp’s recent share price pullback, including a 9.54% 1 month share price return and 4.23% 7 day share price return, sits against a stronger backdrop. A 16.16% year to date share price return and 34.48% 1 year...

Wondering whether Phillips 66 at around US$174 a share is still offering value, or if the easy money has already been made? This article walks through what the numbers actually say about the stock. The share price has recently moved by 4.6% over the last 7 days, 10.7% over 30 days, 33.3% year to date and 47.3% over the past year, which may have changed how investors think about both its upside and its risks. These returns also sit alongside a longer-term picture, with the stock recording a...

Thermon Group Holdings (THR) has caught investor attention after a strong year, with a 64.75% 1 year total return and year to date performance of 23.62% as of the latest close. See our latest analysis for Thermon Group Holdings. The recent 1 month share price return of 7.42% and 1 day move of 0.89% lower sit against a stronger 90 day share price return of 15.64% and 1 year total shareholder return of 63.75%. This suggests momentum has been building despite some near term cooling around the...

Medtronic (MDT) is back in focus after reporting better-than-expected Q3 2026 results, highlighting 6% organic revenue growth and affirming a quarterly dividend of $0.71 per share that extends its dividend aristocrat record. See our latest analysis for Medtronic. Despite the Q3 beat, Medtronic’s recent share price performance has been weak, with a 30 day share price return of 13.84% and a year to date share price return of 9.03%. The 3 year total shareholder return of 21.56% contrasts with a...

If you are wondering whether Gorman-Rupp at around US$59 a share offers good value today, this article will walk through what the current price actually reflects. The stock is down about 5.6% over the last week and 10.8% over the last month, while still sitting on a 22.9% year-to-date return and a 63.5% return over the past year. Recent attention has focused on Gorman-Rupp as investors reassess companies in the capital goods space, with an eye on how pump and fluid handling businesses are...

Earlier in March 2026, Ciena reported first-quarter revenue of US$1,427.04 million and net income of US$150.28 million, raised its full-year 2026 revenue guidance to US$5.90–US$6.30 billion, and completed a US$410.26 million share repurchase program while providing second-quarter revenue guidance of about US$1.50 billion plus or minus US$50 million. Around the same time, Ciena also highlighted advanced optical, AI-oriented, and quantum-secure networking innovations at OFC 2026, underscoring...

If you are wondering whether Freeport McMoRan is offering fair value at its current share price, you are not alone. This article will walk through how that price stacks up against a few common valuation checks. The stock last closed at US$59.21, with returns of 14.0% year to date and 59.7% over the past year, although the price has seen a 5.5% decline over the last 7 days and a 6.4% decline over the past 30 days. Recent market attention on Freeport McMoRan has been shaped by broader interest...

SEI Investments (NasdaqGS:SEIC) reports sustained strong revenue growth and profitability. The company highlights an outstanding return on equity that points to efficient operations. Management attributes performance to a robust competitive moat in its core investment services and technology offerings. The recent data show annualized revenue and EPS growth running ahead of past averages. SEI Investments, known for its investment processing, asset management, and technology platforms, is...

If you are wondering whether H.B. Fuller at around US$55.30 is a bargain or just fairly priced, you are not alone. This article is built to help you test that idea with numbers rather than gut feel. The stock has seen a 10.3% decline over the last 7 days, a 16.7% decline over the last 30 days, and is down 8.4% year to date. However, the 1 year return sits at 6.3% and the longer term 3 year and 5 year returns are 12.2% and 3.1% declines respectively. Recent moves in H.B. Fuller shares have...

Why Catalyst Pharmaceuticals Stock Is On Investor Radars Catalyst Pharmaceuticals (CPRX) has attracted fresh attention after recent trading left the share price at $23.39, with returns mixed over the past week, month and past 3 months. See our latest analysis for Catalyst Pharmaceuticals. Recent trading weakness, including a 4.16% 1 day share price decline and softer 7 and 30 day share price returns, sits against a stronger backdrop, with 1 year total shareholder return of 12.07% and a very...

In March 2026, Serve Robotics Inc. filed a US$19.37 million shelf registration for 1,819,151 common shares tied to its employee stock plans, and earlier that month it and White Castle announced a partnership to use Serve’s autonomous sidewalk robots for Uber Eats deliveries in select U.S. cities. The combination of this new collaboration and Serve’s raised 2026 revenue outlook to approximately US$26 million highlights how its expanding robot fleet and multi-vertical platform, including...

If you are wondering whether CECO Environmental's share price still reflects its true worth after a strong run, this article will walk through what the current numbers actually suggest. The stock most recently closed at US$54.29, with a 1 year return of 137.3% and a 3 year gain of about 3x, even though the last 30 days show a 26.1% decline and the year to date return sits at a 9.2% decline. Recent coverage has focused on CECO's position in industrial air quality and fluid handling solutions,...

Danaos Corporation recently filed an omnibus shelf registration that covers common and preferred stock, debt securities, warrants, purchase contracts, rights, units, and depositary shares, giving it flexibility to issue a wide range of securities over time. This filing follows the completion of a share repurchase program that retired about 3.25 million shares for roughly US$235.06 million, signaling active balance sheet management alongside potential future capital-raising options. We’ll now...

With no single headline event driving attention, Casey's General Stores (CASY) is drawing interest as investors weigh its recent share performance, business scale, and profitability against broader consumer retail peers. See our latest analysis for Casey's General Stores. At a latest share price of $673.81, Casey's General Stores has paired a recent 90 day share price return of 24.76% with a 1 year total shareholder return of 75.74%, which indicates that investors have been reassessing its...

Zevra Therapeutics (ZVRA) is back in focus after reporting better-than-expected Q4 and full-year 2025 earnings, reaching profitability as MIPLYFFA sales, EMA filing plans, and a new GeneDx partnership reshape its rare disease profile. See our latest analysis for Zevra Therapeutics. The stock has pulled back, with a 1-day share price decline of 2.16% to US$10.19. However, recent news around MIPLYFFA, EMA progress, the GeneDx partnership and the new CFO hire comes against a 22.3% 90-day share...

If you are wondering whether Keurig Dr Pepper is starting to look interesting at current levels, the key question is whether the recent share price fairly reflects its underlying value. The stock closed at US$26.93, with returns of a 4.0% decline over 7 days, a 6.2% decline over 30 days, a 2.9% decline year to date, a 16.1% decline over 1 year, a 16.6% decline over 3 years and a 10.0% decline over 5 years. This performance may catch the eye of investors reassessing potential risk and...